HUE053671T2 - Gliceril-tribenzoátot tartalmazó készítmény neurodegeneratív rendellenességben történõ alkalmazása - Google Patents

Gliceril-tribenzoátot tartalmazó készítmény neurodegeneratív rendellenességben történõ alkalmazása

Info

Publication number
HUE053671T2
HUE053671T2 HUE15737329A HUE15737329A HUE053671T2 HU E053671 T2 HUE053671 T2 HU E053671T2 HU E15737329 A HUE15737329 A HU E15737329A HU E15737329 A HUE15737329 A HU E15737329A HU E053671 T2 HUE053671 T2 HU E053671T2
Authority
HU
Hungary
Prior art keywords
composition
neurodegenerative disorder
glyceryl tribenzoate
tribenzoate
glyceryl
Prior art date
Application number
HUE15737329A
Other languages
English (en)
Hungarian (hu)
Inventor
Kalipada Pahan
Original Assignee
Univ Rush Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rush Medical Center filed Critical Univ Rush Medical Center
Publication of HUE053671T2 publication Critical patent/HUE053671T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
HUE15737329A 2014-01-17 2015-01-16 Gliceril-tribenzoátot tartalmazó készítmény neurodegeneratív rendellenességben történõ alkalmazása HUE053671T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201461928622P 2014-01-17 2014-01-17

Publications (1)

Publication Number Publication Date
HUE053671T2 true HUE053671T2 (hu) 2021-07-28

Family

ID=53543490

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE15737329A HUE053671T2 (hu) 2014-01-17 2015-01-16 Gliceril-tribenzoátot tartalmazó készítmény neurodegeneratív rendellenességben történõ alkalmazása

Country Status (16)

Country Link
US (1) US9968582B2 (https=)
EP (1) EP3094616B1 (https=)
JP (2) JP6836905B2 (https=)
CA (1) CA2936548C (https=)
CY (1) CY1124115T1 (https=)
DK (1) DK3094616T3 (https=)
ES (1) ES2853974T3 (https=)
HR (1) HRP20210361T1 (https=)
HU (1) HUE053671T2 (https=)
LT (1) LT3094616T (https=)
PL (1) PL3094616T3 (https=)
PT (1) PT3094616T (https=)
RS (1) RS61611B1 (https=)
SI (1) SI3094616T1 (https=)
SM (1) SMT202100074T1 (https=)
WO (1) WO2015109215A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA202090666A1 (ru) * 2017-10-06 2020-08-05 Раш Юниверсити Медикал Сентер Применение содержащей бензоат композиции для лечения глициновой энцефалопатии
JP7034314B2 (ja) * 2017-11-22 2022-03-11 潔欣 林 うつ病を予防または治療するための安息香酸またはその塩および誘導体
US12478598B2 (en) 2019-02-25 2025-11-25 Rush University Medical Center Compositions including cinnamic acid and methods of use thereof
CN114502154A (zh) * 2019-07-16 2022-05-13 拉什大学医学中心 含苯甲酸酯的组合物治疗神经退行性疾病的用途
CN116390761A (zh) * 2020-10-28 2023-07-04 拉什大学医学中心 肉桂酸苄酯组合物在治疗甘氨酸脑病和尿素循环障碍中的应用
CA3205005A1 (en) * 2020-12-16 2022-06-23 Rush University Medical Center Administration of glycerol tribenzoate and glycerol phenylbutyrate for treatment of neurodegenerative and urea cycle disorders
JP2025503457A (ja) * 2021-12-16 2025-02-04 ザ ユナイテッド ステイツ ガバメント アズ リプレゼンティド バイ ザ デパートメント オブ ヴェテランズ アフェアーズ 神経系損傷及び障害の治療のための安息香酸塩

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284647A (en) * 1980-03-31 1981-08-18 The Johns Hopkins University Process for waste nitrogen removal
WO2008083226A2 (en) 2006-12-28 2008-07-10 Navinta Llc Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate

Also Published As

Publication number Publication date
CY1124115T1 (el) 2022-05-27
EP3094616B1 (en) 2020-12-23
US9968582B2 (en) 2018-05-15
ES2853974T3 (es) 2021-09-20
SI3094616T1 (sl) 2021-07-30
JP2017505811A (ja) 2017-02-23
SMT202100074T1 (it) 2021-05-07
CA2936548A1 (en) 2015-07-23
US20160331714A1 (en) 2016-11-17
EP3094616A1 (en) 2016-11-23
HRP20210361T1 (hr) 2021-04-16
RS61611B1 (sr) 2021-04-29
CA2936548C (en) 2022-08-30
JP2020037558A (ja) 2020-03-12
LT3094616T (lt) 2021-04-12
PL3094616T3 (pl) 2021-05-31
WO2015109215A1 (en) 2015-07-23
JP6836905B2 (ja) 2021-03-03
EP3094616A4 (en) 2017-08-23
PT3094616T (pt) 2021-03-03
DK3094616T3 (da) 2021-02-15

Similar Documents

Publication Publication Date Title
IL258931A (en) Therapeutic compounds and methods
DK4137116T3 (da) Sammensætning omfattende mikronålepartikler
EP3513809A4 (en) MEDICAL COMPOSITION
BR112016013333A2 (pt) composição para cuidado oral
DK3030262T3 (da) Kombineret farmaceutisk sammensætning
DK3132034T3 (da) Terapeutikum
EP3002632A4 (en) LIGHT-CURABLE ACRYLIC COMPOSITION
EP2958994A4 (en) Vaccine composition
BR112016021011A2 (pt) composição tópica e usos de um composto
EP2961397A4 (en) TRANSDERMAL FORMULATIONS
FI20146023A7 (fi) Hammas- ja kielituki
HUE053671T2 (hu) Gliceril-tribenzoátot tartalmazó készítmény neurodegeneratív rendellenességben történõ alkalmazása
PL3194421T3 (pl) Związki cytotoksyczne i przeciwmitotyczne oraz sposoby ich wykorzystania
PL3207149T3 (pl) Kompozycja farmaceutyczna o zwiększonej stabilności
IL250649A0 (en) Topical composition containing ranpirnase
CL2016001687A1 (es) Colorante-polímero
BR112017007645A2 (pt) composições para tratar feridas
PL3145592T3 (pl) Kompozycja do pielęgnacji skóry
DK3140050T3 (da) Dosering med visning
EP2994184C0 (en) An unravelable catheter
FR3021528B1 (fr) Formulation cosmetique
BR112017012633A2 (pt) composição para higiene bucal
DK3089740T3 (da) Farmaceutisk sammensætning
FR3007291B1 (fr) Composition cicatrisante et utlisation
EP3441073A4 (en) MEDICAL COMPOSITION